Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.

Importers of laboratory reagents and materials used in the manufacture of medicines in the UK’s life sciences sector have been given a six-month extension to make the necessary changes to their supply chains for new post-Brexit border paperwork and border inspections.